Clinical applications of therapeutic phlebotomy

References

• ParapiaLAHistory of bloodletting by phlebotomyBr J Haematol2008143449049518783398
   PubMed Web of Science ®Google Scholar
• SchneebergNGA twenty-first century perspective on the ancient art of bloodlettingTrans Stud Coll Physicians Phila20022415718512800324
   PubMedGoogle Scholar
• EstesJWGeorge Washington and the doctors: treating America’s first superheroMed Herit198511445711620646
   PubMedGoogle Scholar
• SajidMIHijama therapy (wet cupping) – its potential use to complement British healthcare in practice, understanding, evidence and regulationComplement Ther Clin Pract20162391327157951
   PubMed Web of Science ®Google Scholar
• El SayedSMMahmoudHSNaboMMHMedical and scientific bases of wet cupping therapy (Al-hijamah): in light of modern medicine and prophetic medicineAltern Integ Med20132122
   Google Scholar
• CaoHHanMZhuXLiuJAn overview of systematic reviews of clinical evidence for cupping therapyJ Tradit Chin Med Sci201521310
   Google Scholar
• AssiTBBazECurrent applications of therapeutic phlebotomyBlood Transfus201412suppl 1s75s8324120605
   PubMed Web of Science ®Google Scholar
• ZubairATherapeutic phlebotomyClin Liv Dis201445102106
   PubMedGoogle Scholar
• CookLSTherapeutic phlebotomy: a review of diagnoses and treatment considerationsJ Infus Nurs2010332818820228645
   PubMedGoogle Scholar
• BoseNKanzariyaHRole of therapeutic apheresis and phlebotomy techniques in anaesthesia and critical careIndian J Anaesth201458567267825535434
   PubMedGoogle Scholar
• MarchioliRFinazziGSpecchiaGMasciulliAMennittoMRBarbuiTThe CYTO-PV: a large-scale trial testing the intensity of CYTOreductive therapy to prevent cardiovascular events in patients with polycythemia veraThrombosis201120119
   Google Scholar
• MarchioliRFinazziGSpecchiaGCYTO-PV Collaborative GroupCardiovascular events and intensity of treatment in polycythemia veraN Engl J Med20133681223323216616
   PubMed Web of Science ®Google Scholar
• BornsteinRMenonDYorkESprouleBZakCEffects of venesection on cerebral function in chronic lung diseaseCan J Neurol Sci1980742932966783288
   PubMed Web of Science ®Google Scholar
• ChettyKGLightRWStansburyDWMilneNExercise performance of polycythemic chronic obstructive pulmonary disease patients: effect of phlebotomiesChest1990985107310772225946
   PubMed Web of Science ®Google Scholar
• PiccirilloGFimognariFLValdiviaJLMariglianoVEffects of phlebotomy on a patient with secondary polycythemia and angina pectorisInt J Cardiol19944421751778045664
   PubMed Web of Science ®Google Scholar
• WarnesCAWilliamsRGBashoreTMChildJSConnollyHMDearaniJAACC/AHA 2008 Guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to develop guidelines on the management of adults with congenital heart disease)Circulation200811823e714e83318997169
   PubMed Web of Science ®Google Scholar
• AndersenRVTybjaerg-HansenAAppleyardMBirgensHNordestgaardBGHemochromatosis mutations in the general population: iron overload progression rateBlood200410382914291915070663
   PubMed Web of Science ®Google Scholar
• AdamsPCBartonJCHow I treat hemochromatosisBlood2010116331732520308595
   PubMed Web of Science ®Google Scholar
• BaconBRAdamsPCKowdleyKVPowellLWTavillASDiagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver DiseasesHepatology201154132834321452290
   PubMed Web of Science ®Google Scholar
• RamsyCAJagnusIATurnbullABakerHThe treatment of porphyria cutanea tarda by venesectionQ J Med1974431691244822971
   PubMedGoogle Scholar
• RocchiEGibertiniPCassanelliMPietrangeloABorghiAVenturaESerum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tardaJ Lab Clin Med1986107136423941293
   PubMed Web of Science ®Google Scholar
• ClinicalTrials.gov [webpage on the Internet]Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis2007 Available from: http://www.clinicaltrials.gov/ct2/show/NCT00509652Accessed July 27,2007
   Google Scholar
• BouchaïrNManignePKanferAPrevention of sickle cell crises with multiple phlebotomiesArch Pediatric200073249255
   Web of Science ®Google Scholar
• RombosYTzaneteaRKalotychouVAmelioration of painful crises in sickle cell disease by venesectionsBlood Cells Mol Dis200228228328712064923
   PubMed Web of Science ®Google Scholar
• AygunBMortierNAKeslerKStroke with transfusions changing to hydroxyurea (SWiTCH) trial investigators. Therapeutic phlebotomy is safe in children with sickle cell anaemia and can be effective treatment for transfusional iron overloadBr J Haematol2015169226226625612463
   PubMed Web of Science ®Google Scholar
• SummarellCCSheehanVAUse of hydroxyurea and phlebotomy in pediatric patients with hemoglobin sickle cell diseaseExp Biol Med (Maywood)2016241773774426993671
   PubMed Web of Science ®Google Scholar
• ByrneCDTargherGNAFLD: a multisystem diseaseJ Hepatol2015621 supplS47S6425920090
   PubMed Web of Science ®Google Scholar
• MilicSMikolasevicIKrznaric-ZrnicINonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsDrug Des Devel Ther2015948354845
   Web of Science ®Google Scholar
• KoplayMSivriMErdoganHNaymanAImportance of imaging and recent developments in diagnosis of nonalcoholic fatty liver diseaseWorld J Hepatol20157576977625914777
   PubMed Web of Science ®Google Scholar
• MarchesiniGBugianesiEForlaniGNonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeHepatology200337491792312668987
   PubMed Web of Science ®Google Scholar
• ValentiLFracanzaniALDongiovanniPA randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemiaWorld J Gastroenterol201420113002301024659891
   PubMed Web of Science ®Google Scholar
• DongiovanniPFracanzaniALFargionSValentiLIron in fatty liver and in the metabolic syndrome: a promising therapeutic targetJ Hepatol201155492093221718726
   PubMed Web of Science ®Google Scholar
• AdamsLACrawfordDHStuartKThe impact of phlebotomy in nonalcoholic fatty liver disease: a prospective, randomized, controlled trialHepatology20156151555156425524401
   PubMed Web of Science ®Google Scholar
• Ahfsdruginformation.com [homepage on the Internet]Bethesda: AHFS Drug Information^®; c2009-10 [updated 2015 Nov 17; cited 2015 Dec 3]. Available from: http://www.ahfsdruginformation.com/Accessed December 29, 2015
   Google Scholar
• RobackJTechnical Manual16th edArlington, VAAABB2008
   Google Scholar
• JahangiriMRaynerAKeoghBLincolnCCerebrovascular accident after vacuum-assisted venous drainage in a Fontan patient: a cautionary taleAnn Thorac Surg20017251727172811722073
   PubMed Web of Science ®Google Scholar
• LotterleJSchellmannBUnbekannte Gefahr bei Adelaß mit Unterdruckflaschen: Luftembolie [Unknown danger in phlebotomy with vacuum flasks: air embolism]Zeitschrift fur Rechtsmedizin198054247254 German
   Google Scholar
• SiegelPPetridesPECongenital and acquired polycythemiasDeutsches Aerzteblatt Int200810546268
   Web of Science ®Google Scholar
• Iron Disorders InstituteTherapeutic Phlebotomy Treatment for Iron OverloadGreenville, SCIron Disorders Institute2004354
   Google Scholar
• KesslerCSMcGuinnMSpecAChristensenJBaragiRHershowRCUnderreporting of blood and body fluid exposures among health care students and trainees in the acute care setting: a 2007 surveyAm J Infect Control201139212913421356431
   PubMed Web of Science ®Google Scholar
• Prüss-UstünARapitiEHutinYEstimation of the global burden of disease attributable to contaminated sharps injuries among health-care workersAm J Ind Med200548648249016299710
   PubMed Web of Science ®Google Scholar
• KassaGSelenicDLahuertaMOccupational exposure to blood-borne pathogens among health care workers in Botswana: reporting and utilization of postexposure prophylaxisAm J Infect Control Epub2016324
   Web of Science ®Google Scholar